| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977890 | Brachytherapy | 2012 | 5 Pages |
Abstract
Real-time planned low-dose-rate prostate brachytherapy provides excellent biochemical control as a single-agent treatment for low-risk prostate cancer with 91.1% freedom from BCF at 72 months. Only prostate volume less than 25Â cc was an independent predictor of BCF.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Wilhelm Lubbe, Randi Cohen, Navesh Sharma, Karen Ruth, Ruth Peters, Jinsheng Li, Mark Buyyounouski, Alexander Kutikov, David Chen, Robert Uzzo, Eric Horwitz,